Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 16, 2019 08:28 ET | Source: Viveve Medical, Inc.

Viveve Reports Preliminary Full Year 2018 Financial Results, Announces 2019 Revenue Guidance and Provides Corporate Update

- Company reports $18.5 million in preliminary full year 2018 revenue, representing 21% year-over-year growth, and announces revenue guidance of $20.0 million for 2019 - Company undergoes...
January 03, 2019 08:28 ET | Source: Viveve Medical, Inc.

Viveve Completes Enrollment in LIBERATE-International Trial for Improvement of Stress Urinary Incontinence

ENGLEWOOD, Colo., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, announced today that it has completed...
December 20, 2018 16:50 ET | Source: Viveve Medical, Inc.

Viveve Announces FDA Clearance to Advance VIVEVE II Clinical Study to Full Enrollment

- Sites to continue enrollment up to 250 patients in sexual function trial - ENGLEWOOD, Colo., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company...
December 11, 2018 16:05 ET | Source: Viveve Medical, Inc.

Viveve Announces Closing of Public Offering of Shares of Common Stock

ENGLEWOOD, Colo., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (“Viveve”) (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced the closing of...
December 06, 2018 21:49 ET | Source: Viveve Medical, Inc.

Viveve Announces Pricing of Public Offering of Shares of Common Stock

ENGLEWOOD, Colo., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (“Viveve”) (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced the pricing of an...
December 06, 2018 16:03 ET | Source: Viveve Medical, Inc.

Viveve Announces Positive 12-Month Data from Stress Urinary Incontinence Feasibility Study

— 72% of women treated experienced an improvement in the one-hour pad weight with an overall mean improvement of 56% — Clinically meaningful benefit achieved at one year across all...
December 06, 2018 16:01 ET | Source: Viveve Medical, Inc.

Viveve Announces Proposed Public Offering of Shares of Common Stock

ENGLEWOOD, Colo., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (“Viveve”) (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced that it has...
November 29, 2018 08:28 ET | Source: Viveve Medical, Inc.

Viveve to Host Stress Urinary Incontinence Symposium with Physician Opinion Leaders

Twelve-month data from the SUI feasibility study to be presented ENGLEWOOD, Colo., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on...
November 15, 2018 16:28 ET | Source: Viveve Medical, Inc.

Viveve Named One of North America’s 500 Fastest Growing Companies by Deloitte

Company awarded sixth place overall and is only medical device company listed in the top ten ENGLEWOOD, Colo., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical...
November 08, 2018 17:30 ET | Source: Viveve Medical, Inc.

Viveve to Present at Stifel 2018 Healthcare Conference

ENGLEWOOD, Colo., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief...